Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Feb 6, 2026 3:59:54 PM EST

16.33USD+9.231%(+1.38)303,834

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 6, 2026 9:25:30 AM EST

15.47USD+3.478%(+0.52)3,539

After-hours

Feb 6, 2026 4:42:30 PM EST

16.23USD-0.612%(-0.10)697

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

208.70M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Mar 17, 2026 (36d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

379,096

Avg. Vol. 30 Day

453,686

Employees

Market Cap

208,701,286

Shares Out.

12,788,069

On/Off Exchange

50%/50%

6 Month Beta

2.98

1 Year Beta

1.08

2 Year Beta

1.11

3 Year Beta

1.17

52 Week Low

6.76

52 Week High

69.97

SMA50

17.11

SMA200

26.73

1 Week

-5.17%

1 Month

+7.58%

3 Month

-4.00%

6 Month

-64.90%

1 Year

+31.72%

2 Year

-98.45%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $16.33, and today's volume is 303,834. TNXP is up 9.231% today. The 30 day average volume is 453,686. TNXP market cap is 208.70M with 12,788,069 shares outstanding.